# Norgesic

NDC: 61825-305
Generic name: Orphenadrine Citrate, Aspirin and Caffeine
Labeler / Manufacturer: Galt Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220516

FDA application: ANDA075141

## Active ingredients

- ASPIRIN: 385 mg/1
- CAFFEINE: 30 mg/1
- ORPHENADRINE CITRATE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61825-305"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61825-305
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be2761bc-e537-4039-846a-2ffa3d8b2afc